Company's treatment for spinal fractures gaining attention
[caption id="attachment_18134" align="alignleft" width="202" caption="Osseon Therapeutics' flexible needle allows it to pinpoint vertebral fractions and deliver bone cement."][/caption]
SANTA ROSA – Medical device startup Osseon Therapeutics has reached break-even in three short years, and its bone cement delivery system is in high demand among physicians and surgery centers, said a company spokesman.
After obtaining FDA approval and launching its Osseoflex system last year, Osseon has passed its 530th case and is one of only two companies approved for cavity creation (Osseoplasty) by Medicare. The other is Medtronic.
The system was patented by Y. King Liu, a 40-year academic researcher, clinical practitioner and biomedical engineering device developer and the founder of the University of Northern California in Santa Rosa.
Dr. Liu invented the delivery system in conjunction with longer-lasting bone cement for the performance of Kyphoplasty, a surgical procedure to repair vertebral bone.